Brief: ChemoTech Q4 EPS SEK -0.35
05/03/2024 11:10
Mar 5 (Reuters) - ChemoTech Q4 order backlog SEK 600 thousand. * Q4 sales SEK 507 thousand * Q4 EPS SEK -0.35 * Q4 operating cash flow SEK -3.396 million * Q4 pretax profit SEK -5.148 million
Recent news on Scandinavian ChemoTech AB
See all newsBrief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue
Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Brief: ChemoTech Q1 Sales SEK 2.798 Million